

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 6.95125548 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 6.95125548 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.95125548 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.95125548 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.95125548 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 6.95125548 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.76236194 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.30440429 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 5.01272050 |
| 10 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.77638098 |
| 11 | response to host immune response (GO:0052572) | 4.63113184 |
| 12 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.63113184 |
| 13 | positive regulation of interferon-alpha production (GO:0032727) | 4.58656484 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 4.53575981 |
| 15 | interkinetic nuclear migration (GO:0022027) | 4.49883683 |
| 16 | regulation of interferon-alpha production (GO:0032647) | 4.39364164 |
| 17 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 4.31860958 |
| 18 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 4.31860958 |
| 19 | regulation of translation, ncRNA-mediated (GO:0045974) | 4.31860958 |
| 20 | response to host (GO:0075136) | 4.22372269 |
| 21 | response to host defenses (GO:0052200) | 4.22372269 |
| 22 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.22372269 |
| 23 | response to peptidoglycan (GO:0032494) | 4.13954532 |
| 24 | microglial cell activation (GO:0001774) | 3.96674164 |
| 25 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.94792219 |
| 26 | respiratory burst (GO:0045730) | 3.93832906 |
| 27 | immunoglobulin mediated immune response (GO:0016064) | 3.80236395 |
| 28 | cellular extravasation (GO:0045123) | 3.73578644 |
| 29 | neutrophil mediated immunity (GO:0002446) | 3.71793502 |
| 30 | I-kappaB phosphorylation (GO:0007252) | 3.69254960 |
| 31 | myeloid cell activation involved in immune response (GO:0002275) | 3.64129540 |
| 32 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.61546507 |
| 33 | response to muramyl dipeptide (GO:0032495) | 3.60848543 |
| 34 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.57418227 |
| 35 | regulation of gene silencing by miRNA (GO:0060964) | 3.57418227 |
| 36 | regulation of gene silencing by RNA (GO:0060966) | 3.57418227 |
| 37 | regulation of cholesterol storage (GO:0010885) | 3.54101682 |
| 38 | pinocytosis (GO:0006907) | 3.51734392 |
| 39 | positive regulation of interferon-beta production (GO:0032728) | 3.49013585 |
| 40 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.47938631 |
| 41 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.43764525 |
| 42 | natural killer cell mediated immunity (GO:0002228) | 3.43764525 |
| 43 | detection of other organism (GO:0098543) | 3.39717419 |
| 44 | macrophage activation (GO:0042116) | 3.38127983 |
| 45 | neutrophil activation (GO:0042119) | 3.35761623 |
| 46 | granulocyte activation (GO:0036230) | 3.34137892 |
| 47 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.33694673 |
| 48 | activated T cell proliferation (GO:0050798) | 3.32116852 |
| 49 | neural tube formation (GO:0001841) | 3.30225359 |
| 50 | definitive hemopoiesis (GO:0060216) | 3.28456200 |
| 51 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.25695074 |
| 52 | detection of bacterium (GO:0016045) | 3.23578131 |
| 53 | positive regulation of B cell differentiation (GO:0045579) | 3.21270452 |
| 54 | negative thymic T cell selection (GO:0045060) | 3.20782669 |
| 55 | histone H3-K4 trimethylation (GO:0080182) | 3.19694040 |
| 56 | mannose metabolic process (GO:0006013) | 3.18637151 |
| 57 | positive regulation of granulocyte differentiation (GO:0030854) | 3.16679681 |
| 58 | negative T cell selection (GO:0043383) | 3.16080664 |
| 59 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.13815042 |
| 60 | pyrimidine dimer repair (GO:0006290) | 3.13474888 |
| 61 | detection of external biotic stimulus (GO:0098581) | 3.09721187 |
| 62 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.08872571 |
| 63 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.08872571 |
| 64 | negative regulation of lipid storage (GO:0010888) | 3.08113721 |
| 65 | low-density lipoprotein particle clearance (GO:0034383) | 3.05970400 |
| 66 | positive regulation of developmental pigmentation (GO:0048087) | 3.05290454 |
| 67 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.04097705 |
| 68 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.04054288 |
| 69 | detection of biotic stimulus (GO:0009595) | 3.03246524 |
| 70 | cell adhesion mediated by integrin (GO:0033627) | 3.00466913 |
| 71 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.99954468 |
| 72 | apoptotic cell clearance (GO:0043277) | 2.99665664 |
| 73 | positive regulation of antigen processing and presentation (GO:0002579) | 2.99567190 |
| 74 | negative regulation of T cell mediated immunity (GO:0002710) | 2.97553787 |
| 75 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.94469482 |
| 76 | positive regulation of mast cell degranulation (GO:0043306) | 2.94469482 |
| 77 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.93903256 |
| 78 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.93173028 |
| 79 | negative regulation of interleukin-12 production (GO:0032695) | 2.93047529 |
| 80 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.93041179 |
| 81 | negative regulation of interleukin-17 production (GO:0032700) | 2.84276664 |
| 82 | histone H3-K9 methylation (GO:0051567) | 2.83800156 |
| 83 | detection of molecule of bacterial origin (GO:0032490) | 2.83743072 |
| 84 | cell proliferation in forebrain (GO:0021846) | 2.83167244 |
| 85 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.79857298 |
| 86 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.78851668 |
| 87 | regulation of interferon-beta production (GO:0032648) | 2.78607749 |
| 88 | regulation of gamma-delta T cell activation (GO:0046643) | 2.78223151 |
| 89 | myeloid leukocyte mediated immunity (GO:0002444) | 2.78060354 |
| 90 | positive T cell selection (GO:0043368) | 2.76420281 |
| 91 | histone H3-K9 modification (GO:0061647) | 2.75884849 |
| 92 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.75797479 |
| 93 | negative regulation of granulocyte differentiation (GO:0030853) | 2.75763036 |
| 94 | negative regulation of cell killing (GO:0031342) | 2.74934247 |
| 95 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.74934247 |
| 96 | interferon-gamma production (GO:0032609) | 2.74576061 |
| 97 | B cell mediated immunity (GO:0019724) | 2.74310482 |
| 98 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.74302461 |
| 99 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.71049767 |
| 100 | response to lipoprotein particle (GO:0055094) | 2.70266759 |
| 101 | positive thymic T cell selection (GO:0045059) | 2.69606362 |
| 102 | leukocyte mediated cytotoxicity (GO:0001909) | 2.68562891 |
| 103 | response to fungus (GO:0009620) | 2.66995393 |
| 104 | histone H3-K36 demethylation (GO:0070544) | 2.65979268 |
| 105 | T-helper 1 type immune response (GO:0042088) | 2.65381090 |
| 106 | adaptation of signaling pathway (GO:0023058) | 2.64284954 |
| 107 | leukocyte aggregation (GO:0070486) | 2.63931086 |
| 108 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.63348949 |
| 109 | myeloid leukocyte activation (GO:0002274) | 2.61657024 |
| 110 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.61289875 |
| 111 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.61062342 |
| 112 | negative regulation of B cell mediated immunity (GO:0002713) | 2.61062342 |
| 113 | mast cell activation (GO:0045576) | 2.60815893 |
| 114 | regulation of mast cell degranulation (GO:0043304) | 2.59770629 |
| 115 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.59753778 |
| 116 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.59153606 |
| 117 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.58879791 |
| 118 | positive regulation of mast cell activation (GO:0033005) | 2.58255555 |
| 119 | regulation of B cell differentiation (GO:0045577) | 2.56578369 |
| 120 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.56556640 |
| 121 | defense response to protozoan (GO:0042832) | 2.55998475 |
| 122 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.55410149 |
| 123 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.55135645 |
| 124 | response to interleukin-15 (GO:0070672) | 2.55068593 |
| 125 | positive regulation of macrophage cytokine production (GO:0060907) | 2.54745659 |
| 126 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.54551297 |
| 127 | regulation of mononuclear cell migration (GO:0071675) | 2.54182212 |
| 128 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.53549904 |
| 129 | regulation of pigment cell differentiation (GO:0050932) | 2.52212779 |
| 130 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.51965887 |
| 131 | regulation of mast cell activation (GO:0033003) | 2.51633167 |
| 132 | response to laminar fluid shear stress (GO:0034616) | 2.51404136 |
| 133 | negative regulation of B cell proliferation (GO:0030889) | 2.51101575 |
| 134 | response to type I interferon (GO:0034340) | 2.50621324 |
| 135 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.49417733 |
| 136 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.49417733 |
| 137 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.49187487 |
| 138 | B cell receptor signaling pathway (GO:0050853) | 2.48941400 |
| 139 | type I interferon signaling pathway (GO:0060337) | 2.48456305 |
| 140 | cellular response to type I interferon (GO:0071357) | 2.48456305 |
| 141 | NIK/NF-kappaB signaling (GO:0038061) | 2.47759359 |
| 142 | cell wall macromolecule catabolic process (GO:0016998) | 2.47664632 |
| 143 | leukocyte cell-cell adhesion (GO:0007159) | 2.46994664 |
| 144 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.46968920 |
| 145 | cellular response to exogenous dsRNA (GO:0071360) | 2.46733048 |
| 146 | protein K11-linked deubiquitination (GO:0035871) | 2.46686835 |
| 147 | T cell migration (GO:0072678) | 2.46163757 |
| 148 | cytokine secretion (GO:0050663) | 2.45513715 |
| 149 | germinal center formation (GO:0002467) | 2.45431135 |
| 150 | regulation of leukocyte degranulation (GO:0043300) | 2.45247620 |
| 151 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.45164000 |
| 152 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.44714118 |
| 153 | protein K48-linked deubiquitination (GO:0071108) | 2.43915497 |
| 154 | mRNA splice site selection (GO:0006376) | 2.43735856 |
| 155 | negative regulation of adaptive immune response (GO:0002820) | 2.40441656 |
| 156 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.40130765 |
| 157 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.39645010 |
| 158 | positive regulation of tolerance induction (GO:0002645) | 2.39512527 |
| 159 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.39311897 |
| 160 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.38905488 |
| 161 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.38645194 |
| 162 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.38408886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.52293819 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.37243457 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.46459846 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.96187665 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.90568656 |
| 6 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.56134082 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.43966591 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.30695479 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.22237191 |
| 10 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.21715626 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.08465288 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.98493780 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.96989263 |
| 14 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.87538233 |
| 15 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.82010646 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.80768699 |
| 17 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.72888790 |
| 18 | * SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.63676696 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.49814085 |
| 20 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.48154237 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.42047401 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.37464103 |
| 23 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.36920248 |
| 24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.35223405 |
| 25 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.28989544 |
| 26 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.19609710 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.19220216 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.14019146 |
| 29 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.10737669 |
| 30 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.05632918 |
| 31 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.02459621 |
| 32 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.02456963 |
| 33 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.99049355 |
| 34 | FUS_26573619_Chip-Seq_HEK293_Human | 1.98285694 |
| 35 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.98235924 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.97744885 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.96776470 |
| 38 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.96345046 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.94535912 |
| 40 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.91955623 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.91325730 |
| 42 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.85153798 |
| 43 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.83579158 |
| 44 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.82130210 |
| 45 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.78666874 |
| 46 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.78666874 |
| 47 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.75103498 |
| 48 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.74024466 |
| 49 | MYB_26560356_Chip-Seq_TH2_Human | 1.71656542 |
| 50 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.69255658 |
| 51 | MAF_26560356_Chip-Seq_TH1_Human | 1.68809025 |
| 52 | VDR_22108803_ChIP-Seq_LS180_Human | 1.67092475 |
| 53 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.66762730 |
| 54 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.66532511 |
| 55 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.66082019 |
| 56 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.66014227 |
| 57 | EWS_26573619_Chip-Seq_HEK293_Human | 1.65483826 |
| 58 | MYB_26560356_Chip-Seq_TH1_Human | 1.61077086 |
| 59 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.61043413 |
| 60 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.60648676 |
| 61 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.59806242 |
| 62 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.59471491 |
| 63 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.59033451 |
| 64 | STAT3_23295773_ChIP-Seq_U87_Human | 1.57247409 |
| 65 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.54884323 |
| 66 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53553424 |
| 67 | MYC_22102868_ChIP-Seq_BL_Human | 1.53381395 |
| 68 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.50926023 |
| 69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.50533457 |
| 70 | TP53_16413492_ChIP-PET_HCT116_Human | 1.50425070 |
| 71 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.49726614 |
| 72 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.48646709 |
| 73 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.46628950 |
| 74 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46496577 |
| 75 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.45622120 |
| 76 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45081689 |
| 77 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.44640585 |
| 78 | RXR_22108803_ChIP-Seq_LS180_Human | 1.43759064 |
| 79 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.43097129 |
| 80 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.42378532 |
| 81 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.42069558 |
| 82 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41930238 |
| 83 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.39277588 |
| 84 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.39268284 |
| 85 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38712033 |
| 86 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.37679657 |
| 87 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.35297003 |
| 88 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35112914 |
| 89 | UTX_26944678_Chip-Seq_JUKART_Human | 1.34392988 |
| 90 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.33389736 |
| 91 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.32835655 |
| 92 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32831416 |
| 93 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32349757 |
| 94 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.32048596 |
| 95 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.31924853 |
| 96 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31643272 |
| 97 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.30882673 |
| 98 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.30333450 |
| 99 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.28510555 |
| 100 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.26744733 |
| 101 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.24464037 |
| 102 | GATA1_22025678_ChIP-Seq_K562_Human | 1.24067560 |
| 103 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.22082220 |
| 104 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21369079 |
| 105 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20440809 |
| 106 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.18725777 |
| 107 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.18544779 |
| 108 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.18377489 |
| 109 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.18125934 |
| 110 | TCF4_23295773_ChIP-Seq_U87_Human | 1.17690765 |
| 111 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.15401140 |
| 112 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14802250 |
| 113 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.14584086 |
| 114 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.14441035 |
| 115 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13837421 |
| 116 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.13448752 |
| 117 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13391151 |
| 118 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12799014 |
| 119 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.12775228 |
| 120 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.12775228 |
| 121 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.11503583 |
| 122 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.11152939 |
| 123 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.09225408 |
| 124 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09026645 |
| 125 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08317394 |
| 126 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.07394209 |
| 127 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06836396 |
| 128 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05478245 |
| 129 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04978398 |
| 130 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.04647541 |
| 131 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02317068 |
| 132 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02164510 |
| 133 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.01809924 |
| 134 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.00859862 |
| 135 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00800150 |
| 136 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.00527187 |
| 137 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00433041 |
| 138 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.00138654 |
| 139 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00081126 |
| 140 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.99881333 |
| 141 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.99772493 |
| 142 | AR_25329375_ChIP-Seq_VCAP_Human | 0.99400587 |
| 143 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99190649 |
| 144 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.99045868 |
| 145 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98650937 |
| 146 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.98368592 |
| 147 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97240194 |
| 148 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.96884346 |
| 149 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96183963 |
| 150 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96078657 |
| 151 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.96065072 |
| 152 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95771979 |
| 153 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.94869588 |
| 154 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94822505 |
| 155 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94621211 |
| 156 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.93776924 |
| 157 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93349022 |
| 158 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89577322 |
| 159 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.89070606 |
| 160 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.89070606 |
| 161 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86954480 |
| 162 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.86925965 |
| 163 | MAF_26560356_Chip-Seq_TH2_Human | 0.86031079 |
| 164 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.82710702 |
| 165 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82236820 |
| 166 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.81029786 |
| 167 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.80850840 |
| 168 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.80849134 |
| 169 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80290475 |
| 170 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79438442 |
| 171 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.77336102 |
| 172 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.75576628 |
| 173 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.73372149 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.76140641 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.46598244 |
| 3 | MP0000569_abnormal_digit_pigmentation | 3.38577761 |
| 4 | MP0003787_abnormal_imprinting | 3.33207264 |
| 5 | MP0003436_decreased_susceptibility_to | 3.31082787 |
| 6 | MP0005058_abnormal_lysosome_morphology | 3.28238666 |
| 7 | MP0006292_abnormal_olfactory_placode | 3.19866239 |
| 8 | MP0008877_abnormal_DNA_methylation | 2.82812446 |
| 9 | MP0002419_abnormal_innate_immunity | 2.76234656 |
| 10 | MP0009840_abnormal_foam_cell | 2.72999621 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.72785275 |
| 12 | MP0006082_CNS_inflammation | 2.64232769 |
| 13 | MP0008057_abnormal_DNA_replication | 2.51611808 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.46233780 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.37597405 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.30057195 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.27656752 |
| 18 | MP0005025_abnormal_response_to | 2.24822589 |
| 19 | MP0001800_abnormal_humoral_immune | 2.24756083 |
| 20 | MP0003878_abnormal_ear_physiology | 2.24743999 |
| 21 | MP0005377_hearing/vestibular/ear_phenot | 2.24743999 |
| 22 | MP0005387_immune_system_phenotype | 2.23397249 |
| 23 | MP0001790_abnormal_immune_system | 2.23397249 |
| 24 | MP0009785_altered_susceptibility_to | 2.16614655 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.13736035 |
| 26 | MP0010307_abnormal_tumor_latency | 2.13326696 |
| 27 | MP0003195_calcinosis | 2.06463659 |
| 28 | MP0009278_abnormal_bone_marrow | 2.05374004 |
| 29 | MP0002723_abnormal_immune_serum | 2.05014788 |
| 30 | MP0002928_abnormal_bile_duct | 2.00913242 |
| 31 | MP0000685_abnormal_immune_system | 2.00227554 |
| 32 | MP0003122_maternal_imprinting | 1.94947353 |
| 33 | MP0001533_abnormal_skeleton_physiology | 1.91324796 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.90246360 |
| 35 | MP0005076_abnormal_cell_differentiation | 1.89594145 |
| 36 | MP0005075_abnormal_melanosome_morpholog | 1.88402283 |
| 37 | MP0003121_genomic_imprinting | 1.88308167 |
| 38 | MP0001819_abnormal_immune_cell | 1.85855929 |
| 39 | MP0002420_abnormal_adaptive_immunity | 1.84322758 |
| 40 | MP0004947_skin_inflammation | 1.83434308 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.83047154 |
| 42 | MP0004510_myositis | 1.82901569 |
| 43 | MP0005671_abnormal_response_to | 1.73373791 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.72685037 |
| 45 | MP0009379_abnormal_foot_pigmentation | 1.67906678 |
| 46 | MP0003690_abnormal_glial_cell | 1.62157616 |
| 47 | MP0000604_amyloidosis | 1.56903809 |
| 48 | MP0002405_respiratory_system_inflammati | 1.53213246 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.53113622 |
| 50 | MP0005257_abnormal_intraocular_pressure | 1.52641167 |
| 51 | MP0002095_abnormal_skin_pigmentation | 1.49377067 |
| 52 | MP0010352_gastrointestinal_tract_polyps | 1.49109345 |
| 53 | MP0004142_abnormal_muscle_tone | 1.48879970 |
| 54 | MP0003566_abnormal_cell_adhesion | 1.46395159 |
| 55 | MP0001986_abnormal_taste_sensitivity | 1.45868369 |
| 56 | MP0005551_abnormal_eye_electrophysiolog | 1.45467233 |
| 57 | MP0002166_altered_tumor_susceptibility | 1.43958350 |
| 58 | MP0002009_preneoplasia | 1.42132146 |
| 59 | MP0003448_altered_tumor_morphology | 1.41762202 |
| 60 | MP0000716_abnormal_immune_system | 1.41206625 |
| 61 | MP0004133_heterotaxia | 1.40359524 |
| 62 | MP0002396_abnormal_hematopoietic_system | 1.39645122 |
| 63 | MP0008469_abnormal_protein_level | 1.39634213 |
| 64 | MP0003252_abnormal_bile_duct | 1.37126441 |
| 65 | MP0001545_abnormal_hematopoietic_system | 1.36939566 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 1.36939566 |
| 67 | MP0000343_altered_response_to | 1.36768877 |
| 68 | MP0002398_abnormal_bone_marrow | 1.35900634 |
| 69 | MP0003763_abnormal_thymus_physiology | 1.34726740 |
| 70 | MP0000689_abnormal_spleen_morphology | 1.34645729 |
| 71 | MP0002653_abnormal_ependyma_morphology | 1.34422670 |
| 72 | MP0003724_increased_susceptibility_to | 1.33662476 |
| 73 | MP0008438_abnormal_cutaneous_collagen | 1.33114063 |
| 74 | MP0008995_early_reproductive_senescence | 1.32373579 |
| 75 | MP0010155_abnormal_intestine_physiology | 1.32260444 |
| 76 | MP0005174_abnormal_tail_pigmentation | 1.31151011 |
| 77 | MP0003943_abnormal_hepatobiliary_system | 1.28229764 |
| 78 | MP0001851_eye_inflammation | 1.27438410 |
| 79 | MP0006072_abnormal_retinal_apoptosis | 1.27277542 |
| 80 | MP0010234_abnormal_vibrissa_follicle | 1.26808312 |
| 81 | MP0003075_altered_response_to | 1.26402877 |
| 82 | MP0001853_heart_inflammation | 1.25962831 |
| 83 | MP0000465_gastrointestinal_hemorrhage | 1.24707931 |
| 84 | MP0005084_abnormal_gallbladder_morpholo | 1.23004670 |
| 85 | MP0000631_abnormal_neuroendocrine_gland | 1.21926931 |
| 86 | MP0005310_abnormal_salivary_gland | 1.18807115 |
| 87 | MP0002006_tumorigenesis | 1.18385801 |
| 88 | MP0004885_abnormal_endolymph | 1.16805382 |
| 89 | MP0002429_abnormal_blood_cell | 1.16728041 |
| 90 | MP0004883_abnormal_blood_vessel | 1.16043914 |
| 91 | MP0003890_abnormal_embryonic-extraembry | 1.15547736 |
| 92 | MP0002722_abnormal_immune_system | 1.14977982 |
| 93 | MP0003091_abnormal_cell_migration | 1.14781920 |
| 94 | MP0004808_abnormal_hematopoietic_stem | 1.14416971 |
| 95 | MP0000858_altered_metastatic_potential | 1.11436873 |
| 96 | MP0009764_decreased_sensitivity_to | 1.06666775 |
| 97 | MP0002277_abnormal_respiratory_mucosa | 1.06142339 |
| 98 | MP0002998_abnormal_bone_remodeling | 1.05688765 |
| 99 | MP0005253_abnormal_eye_physiology | 1.04188914 |
| 100 | MP0004130_abnormal_muscle_cell | 1.03138341 |
| 101 | MP0000371_diluted_coat_color | 1.02826938 |
| 102 | MP0003136_yellow_coat_color | 0.99106068 |
| 103 | MP0009763_increased_sensitivity_to | 0.98997373 |
| 104 | MP0005166_decreased_susceptibility_to | 0.98038054 |
| 105 | MP0003045_fibrosis | 0.97749592 |
| 106 | MP0000427_abnormal_hair_cycle | 0.97425420 |
| 107 | MP0001915_intracranial_hemorrhage | 0.97402414 |
| 108 | MP0001293_anophthalmia | 0.96910334 |
| 109 | MP0000609_abnormal_liver_physiology | 0.95228865 |
| 110 | MP0002163_abnormal_gland_morphology | 0.93601064 |
| 111 | MP0005645_abnormal_hypothalamus_physiol | 0.92548876 |
| 112 | MP0000383_abnormal_hair_follicle | 0.92330120 |
| 113 | MP0009333_abnormal_splenocyte_physiolog | 0.91191528 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.91050446 |
| 115 | MP0005023_abnormal_wound_healing | 0.90752616 |
| 116 | MP0005083_abnormal_biliary_tract | 0.88066959 |
| 117 | MP0005390_skeleton_phenotype | 0.87953343 |
| 118 | MP0000015_abnormal_ear_pigmentation | 0.86768832 |
| 119 | MP0001486_abnormal_startle_reflex | 0.85603383 |
| 120 | MP0003656_abnormal_erythrocyte_physiolo | 0.85164548 |
| 121 | MP0005360_urolithiasis | 0.84241375 |
| 122 | MP0001873_stomach_inflammation | 0.84225069 |
| 123 | MP0006276_abnormal_autonomic_nervous | 0.81425201 |
| 124 | MP0005389_reproductive_system_phenotype | 0.80425697 |
| 125 | MP0005220_abnormal_exocrine_pancreas | 0.80381127 |
| 126 | MP0003828_pulmonary_edema | 0.78080967 |
| 127 | MP0002139_abnormal_hepatobiliary_system | 0.77550554 |
| 128 | MP0002933_joint_inflammation | 0.76479084 |
| 129 | MP0004134_abnormal_chest_morphology | 0.75874357 |
| 130 | MP0009765_abnormal_xenobiotic_induced | 0.75286378 |
| 131 | MP0008961_abnormal_basal_metabolism | 0.74750639 |
| 132 | MP0001286_abnormal_eye_development | 0.74087355 |
| 133 | MP0000598_abnormal_liver_morphology | 0.72658126 |
| 134 | MP0001485_abnormal_pinna_reflex | 0.72260521 |
| 135 | MP0002160_abnormal_reproductive_system | 0.72134575 |
| 136 | MP0003567_abnormal_fetal_cardiomyocyte | 0.71260164 |
| 137 | MP0000733_abnormal_muscle_development | 0.71209592 |
| 138 | MP0002254_reproductive_system_inflammat | 0.71018985 |
| 139 | MP0000778_abnormal_nervous_system | 0.70981368 |
| 140 | MP0000767_abnormal_smooth_muscle | 0.70838431 |
| 141 | MP0002938_white_spotting | 0.70725817 |
| 142 | MP0005195_abnormal_posterior_eye | 0.70157605 |
| 143 | MP0004742_abnormal_vestibular_system | 0.69918436 |
| 144 | MP0005621_abnormal_cell_physiology | 0.68899087 |
| 145 | MP0005164_abnormal_response_to | 0.68881460 |
| 146 | MP0008260_abnormal_autophagy | 0.68759034 |
| 147 | MP0000920_abnormal_myelination | 0.68687275 |
| 148 | MP0005167_abnormal_blood-brain_barrier | 0.68169580 |
| 149 | MP0001501_abnormal_sleep_pattern | 0.68086597 |
| 150 | MP0003283_abnormal_digestive_organ | 0.67883523 |
| 151 | MP0005451_abnormal_body_composition | 0.67815712 |
| 152 | MP0000703_abnormal_thymus_morphology | 0.66988416 |
| 153 | MP0000490_abnormal_crypts_of | 0.66606188 |
| 154 | MP0005379_endocrine/exocrine_gland_phen | 0.65737308 |
| 155 | MP0001958_emphysema | 0.64448480 |
| 156 | MP0005197_abnormal_uvea_morphology | 0.64411255 |
| 157 | MP0004043_abnormal_pH_regulation | 0.64303064 |
| 158 | MP0002822_catalepsy | 0.63107477 |
| 159 | MP0003646_muscle_fatigue | 0.62972157 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.98638541 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.65529464 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.34174184 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.14652563 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 4.59174532 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.09214875 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 4.00004565 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 3.78517649 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.77109037 |
| 10 | Recurrent skin infections (HP:0001581) | 3.63308809 |
| 11 | Myocardial infarction (HP:0001658) | 3.39790733 |
| 12 | Gingivitis (HP:0000230) | 3.39538868 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 3.37655211 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.36900525 |
| 15 | Genetic anticipation (HP:0003743) | 3.36890967 |
| 16 | Hematochezia (HP:0002573) | 3.15326123 |
| 17 | Acute lymphatic leukemia (HP:0006721) | 3.09924446 |
| 18 | Recurrent viral infections (HP:0004429) | 3.08518937 |
| 19 | Pancreatic fibrosis (HP:0100732) | 3.06485688 |
| 20 | Myositis (HP:0100614) | 3.05221581 |
| 21 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.03915763 |
| 22 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.03915763 |
| 23 | Abnormality of glycolipid metabolism (HP:0010969) | 3.03915763 |
| 24 | Periodontitis (HP:0000704) | 3.03099946 |
| 25 | Diastasis recti (HP:0001540) | 2.99611147 |
| 26 | Autoimmune thrombocytopenia (HP:0001973) | 2.98985712 |
| 27 | Pancreatic cysts (HP:0001737) | 2.96467463 |
| 28 | Dysostosis multiplex (HP:0000943) | 2.93538867 |
| 29 | Prostate neoplasm (HP:0100787) | 2.92267626 |
| 30 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.84401773 |
| 31 | Osteolytic defects of the hand bones (HP:0009699) | 2.84401773 |
| 32 | Thick nail (HP:0001805) | 2.84278133 |
| 33 | Axonal loss (HP:0003447) | 2.82603557 |
| 34 | Obstructive lung disease (HP:0006536) | 2.82299998 |
| 35 | Chronic obstructive pulmonary disease (HP:0006510) | 2.82299998 |
| 36 | True hermaphroditism (HP:0010459) | 2.81856196 |
| 37 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.77401815 |
| 38 | Orchitis (HP:0100796) | 2.75304818 |
| 39 | Cellulitis (HP:0100658) | 2.74863639 |
| 40 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.73692689 |
| 41 | Disinhibition (HP:0000734) | 2.73001939 |
| 42 | Stomatitis (HP:0010280) | 2.70993670 |
| 43 | Abolished electroretinogram (ERG) (HP:0000550) | 2.67822394 |
| 44 | Vasculitis (HP:0002633) | 2.61671020 |
| 45 | Glomerulonephritis (HP:0000099) | 2.60374718 |
| 46 | Attenuation of retinal blood vessels (HP:0007843) | 2.59615507 |
| 47 | Stomach cancer (HP:0012126) | 2.57802240 |
| 48 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.57334845 |
| 49 | Nephronophthisis (HP:0000090) | 2.57160357 |
| 50 | Retrobulbar optic neuritis (HP:0100654) | 2.56754752 |
| 51 | Optic neuritis (HP:0100653) | 2.56754752 |
| 52 | Hypochromic microcytic anemia (HP:0004840) | 2.55127415 |
| 53 | Mucopolysacchariduria (HP:0008155) | 2.54982438 |
| 54 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.54982438 |
| 55 | Pustule (HP:0200039) | 2.54550617 |
| 56 | Broad alveolar ridges (HP:0000187) | 2.52587890 |
| 57 | Abnormality of the renal medulla (HP:0100957) | 2.51483118 |
| 58 | Agnosia (HP:0010524) | 2.51148765 |
| 59 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.50049506 |
| 60 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.50049506 |
| 61 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.50049506 |
| 62 | Increased CSF protein (HP:0002922) | 2.48111701 |
| 63 | Panhypogammaglobulinemia (HP:0003139) | 2.45659928 |
| 64 | Upper motor neuron abnormality (HP:0002127) | 2.45296251 |
| 65 | Chronic hepatic failure (HP:0100626) | 2.44581844 |
| 66 | Widely spaced teeth (HP:0000687) | 2.39115884 |
| 67 | Recurrent cutaneous fungal infections (HP:0011370) | 2.38306027 |
| 68 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.38306027 |
| 69 | Loss of speech (HP:0002371) | 2.37884157 |
| 70 | Congenital stationary night blindness (HP:0007642) | 2.35468073 |
| 71 | Arterial thrombosis (HP:0004420) | 2.35260393 |
| 72 | Peripheral demyelination (HP:0011096) | 2.35107048 |
| 73 | Colitis (HP:0002583) | 2.34406145 |
| 74 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.33055140 |
| 75 | Hypoplastic iliac wings (HP:0002866) | 2.31630129 |
| 76 | Supernumerary bones of the axial skeleton (HP:0009144) | 2.31084101 |
| 77 | Progressive cerebellar ataxia (HP:0002073) | 2.30591301 |
| 78 | Supernumerary ribs (HP:0005815) | 2.28968658 |
| 79 | Osteomyelitis (HP:0002754) | 2.28347846 |
| 80 | Joint hemorrhage (HP:0005261) | 2.27866293 |
| 81 | Leukocytosis (HP:0001974) | 2.27156092 |
| 82 | Clumsiness (HP:0002312) | 2.26887561 |
| 83 | Cerebral aneurysm (HP:0004944) | 2.26014949 |
| 84 | Gingival bleeding (HP:0000225) | 2.25565193 |
| 85 | Acute myeloid leukemia (HP:0004808) | 2.21563774 |
| 86 | Hepatoblastoma (HP:0002884) | 2.19556499 |
| 87 | Protruding tongue (HP:0010808) | 2.19290046 |
| 88 | Hepatosplenomegaly (HP:0001433) | 2.18005540 |
| 89 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.16460731 |
| 90 | Complement deficiency (HP:0004431) | 2.14811004 |
| 91 | Eosinophilia (HP:0001880) | 2.12296112 |
| 92 | Abnormality of complement system (HP:0005339) | 2.10462912 |
| 93 | Urticaria (HP:0001025) | 2.08564389 |
| 94 | Decreased central vision (HP:0007663) | 2.08421407 |
| 95 | Nephritis (HP:0000123) | 2.08256159 |
| 96 | Encephalitis (HP:0002383) | 2.07715787 |
| 97 | Spontaneous hematomas (HP:0007420) | 2.07508156 |
| 98 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.07428802 |
| 99 | Inflammation of the large intestine (HP:0002037) | 2.06845938 |
| 100 | Meningitis (HP:0001287) | 2.05008264 |
| 101 | Pathologic fracture (HP:0002756) | 2.04855939 |
| 102 | Gaze-evoked nystagmus (HP:0000640) | 2.04425190 |
| 103 | Urethral obstruction (HP:0000796) | 2.04411370 |
| 104 | Abnormality of DNA repair (HP:0003254) | 2.03999115 |
| 105 | Abnormality of the pubic bones (HP:0003172) | 2.01781973 |
| 106 | Cystic liver disease (HP:0006706) | 2.01767394 |
| 107 | Basal ganglia calcification (HP:0002135) | 2.00178378 |
| 108 | Molar tooth sign on MRI (HP:0002419) | 1.99351840 |
| 109 | Abnormality of midbrain morphology (HP:0002418) | 1.99351840 |
| 110 | Abnormality of secondary sexual hair (HP:0009888) | 1.95817892 |
| 111 | Abnormality of the axillary hair (HP:0100134) | 1.95817892 |
| 112 | Abnormality of the nasal septum (HP:0000419) | 1.95661890 |
| 113 | Prolonged bleeding time (HP:0003010) | 1.95373107 |
| 114 | Gastrointestinal inflammation (HP:0004386) | 1.94971075 |
| 115 | T lymphocytopenia (HP:0005403) | 1.93223078 |
| 116 | Pulmonary infiltrates (HP:0002113) | 1.92580880 |
| 117 | Keratoconjunctivitis (HP:0001096) | 1.92074796 |
| 118 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.89513392 |
| 119 | Absent/shortened dynein arms (HP:0200106) | 1.89513392 |
| 120 | Abnormality of the wing of the ilium (HP:0011867) | 1.87928264 |
| 121 | Albinism (HP:0001022) | 1.87612341 |
| 122 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.87387173 |
| 123 | Short 4th metacarpal (HP:0010044) | 1.87387173 |
| 124 | Thrombocytosis (HP:0001894) | 1.86596489 |
| 125 | Abnormality of the prostate (HP:0008775) | 1.85528559 |
| 126 | Amyloidosis (HP:0011034) | 1.84588250 |
| 127 | Submucous cleft hard palate (HP:0000176) | 1.84120885 |
| 128 | Restrictive lung disease (HP:0002091) | 1.83663477 |
| 129 | Abnormality of T cell number (HP:0011839) | 1.83615273 |
| 130 | Conjunctival telangiectasia (HP:0000524) | 1.82614887 |
| 131 | Growth hormone deficiency (HP:0000824) | 1.82519587 |
| 132 | Medial flaring of the eyebrow (HP:0010747) | 1.81577092 |
| 133 | Abnormality of the parietal bone (HP:0002696) | 1.81420563 |
| 134 | Agammaglobulinemia (HP:0004432) | 1.79615852 |
| 135 | Metaphyseal dysplasia (HP:0100255) | 1.78911097 |
| 136 | Bone pain (HP:0002653) | 1.78677675 |
| 137 | Oligodactyly (hands) (HP:0001180) | 1.77792612 |
| 138 | Hemiplegia (HP:0002301) | 1.77083668 |
| 139 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.76352116 |
| 140 | Thickened calvaria (HP:0002684) | 1.75793619 |
| 141 | Abnormality of the thoracic spine (HP:0100711) | 1.75348381 |
| 142 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.75340956 |
| 143 | Interstitial pulmonary disease (HP:0006530) | 1.75215092 |
| 144 | Thoracic kyphosis (HP:0002942) | 1.75074086 |
| 145 | Anencephaly (HP:0002323) | 1.74585939 |
| 146 | Postaxial foot polydactyly (HP:0001830) | 1.73372800 |
| 147 | Macular degeneration (HP:0000608) | 1.73004146 |
| 148 | Papillary thyroid carcinoma (HP:0002895) | 1.72830375 |
| 149 | Peritonitis (HP:0002586) | 1.72391579 |
| 150 | Congenital hepatic fibrosis (HP:0002612) | 1.72150536 |
| 151 | Keratoconjunctivitis sicca (HP:0001097) | 1.71298334 |
| 152 | Hypochromic anemia (HP:0001931) | 1.71017454 |
| 153 | Severe visual impairment (HP:0001141) | 1.69912637 |
| 154 | Intestinal atresia (HP:0011100) | 1.69449498 |
| 155 | Abnormality of the renal cortex (HP:0011035) | 1.68035687 |
| 156 | Abnormality of the lumbar spine (HP:0100712) | 1.67732071 |
| 157 | Gastrointestinal stroma tumor (HP:0100723) | 1.67204264 |
| 158 | Emphysema (HP:0002097) | 1.67005172 |
| 159 | Hemoptysis (HP:0002105) | 1.66811205 |
| 160 | Hip dysplasia (HP:0001385) | 1.66305573 |
| 161 | Granulocytopenia (HP:0001913) | 1.66278024 |
| 162 | Epistaxis (HP:0000421) | 1.66040759 |
| 163 | Neonatal respiratory distress (HP:0002643) | 1.65524671 |
| 164 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.65401657 |
| 165 | Cupped ear (HP:0000378) | 1.65107396 |
| 166 | Skin ulcer (HP:0200042) | 1.65059383 |
| 167 | Fair hair (HP:0002286) | 1.64684271 |
| 168 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.63672913 |
| 169 | Chest pain (HP:0100749) | 1.63034761 |
| 170 | Amyotrophic lateral sclerosis (HP:0007354) | 1.61955703 |
| 171 | Subacute progressive viral hepatitis (HP:0006572) | 1.61786713 |
| 172 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.61758619 |
| 173 | Gastrointestinal infarctions (HP:0005244) | 1.61561383 |
| 174 | Persistence of primary teeth (HP:0006335) | 1.61309692 |
| 175 | Bilateral microphthalmos (HP:0007633) | 1.59795945 |
| 176 | Decreased circulating renin level (HP:0003351) | 1.58696365 |
| 177 | Increased IgE level (HP:0003212) | 1.58566801 |
| 178 | Pendular nystagmus (HP:0012043) | 1.57744914 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.01345813 |
| 2 | TYK2 | 2.88996305 |
| 3 | MAP3K14 | 2.79639180 |
| 4 | BLK | 2.66106823 |
| 5 | KIT | 2.65903182 |
| 6 | RIPK4 | 2.50815876 |
| 7 | CSF1R | 2.48687732 |
| 8 | TAOK3 | 2.24722490 |
| 9 | TRIB3 | 2.22418230 |
| 10 | TBK1 | 2.21056504 |
| 11 | IRAK3 | 2.18784460 |
| 12 | IRAK4 | 2.14092579 |
| 13 | ERN1 | 2.08003238 |
| 14 | BRD4 | 2.07361831 |
| 15 | JAK1 | 2.06479632 |
| 16 | EPHB1 | 2.02156518 |
| 17 | CAMK1D | 2.01774721 |
| 18 | JAK3 | 1.99599576 |
| 19 | AKT3 | 1.98824032 |
| 20 | MAP3K10 | 1.95850666 |
| 21 | PTK6 | 1.90893165 |
| 22 | SIK1 | 1.88881282 |
| 23 | TGFBR2 | 1.87847543 |
| 24 | TTN | 1.84226700 |
| 25 | CDK19 | 1.73855368 |
| 26 | STK10 | 1.73385612 |
| 27 | PKN2 | 1.72273596 |
| 28 | MAP3K6 | 1.64724290 |
| 29 | IKBKE | 1.51545090 |
| 30 | IKBKB | 1.51245771 |
| 31 | BTK | 1.47922246 |
| 32 | HCK | 1.45639103 |
| 33 | CDK12 | 1.43626063 |
| 34 | ACVR1B | 1.42120366 |
| 35 | BMPR1B | 1.40825709 |
| 36 | MKNK1 | 1.40742966 |
| 37 | PIK3CG | 1.40097731 |
| 38 | NUAK1 | 1.39683357 |
| 39 | CSK | 1.34954254 |
| 40 | ZAP70 | 1.31185396 |
| 41 | MKNK2 | 1.30546120 |
| 42 | CAMK1G | 1.29973852 |
| 43 | FES | 1.28508540 |
| 44 | TNK2 | 1.27909045 |
| 45 | SCYL2 | 1.26680493 |
| 46 | CHUK | 1.24803519 |
| 47 | FLT3 | 1.23736457 |
| 48 | MAP3K4 | 1.20946018 |
| 49 | FGFR2 | 1.20701913 |
| 50 | SIK2 | 1.20086021 |
| 51 | SGK2 | 1.19989488 |
| 52 | IRAK1 | 1.18476882 |
| 53 | MAP3K13 | 1.15556980 |
| 54 | NEK9 | 1.12971336 |
| 55 | JAK2 | 1.12156379 |
| 56 | STK11 | 1.11465404 |
| 57 | FGFR4 | 1.11395740 |
| 58 | LCK | 1.10820105 |
| 59 | PAK4 | 1.10018935 |
| 60 | MAP2K3 | 1.09838485 |
| 61 | TXK | 1.08608032 |
| 62 | TNIK | 1.08033607 |
| 63 | STK4 | 1.07513247 |
| 64 | WNK3 | 1.07477014 |
| 65 | CDK6 | 1.07295106 |
| 66 | EEF2K | 1.06024226 |
| 67 | MARK3 | 1.05763053 |
| 68 | SYK | 1.04877930 |
| 69 | STK3 | 1.02974357 |
| 70 | MAP3K7 | 1.01871992 |
| 71 | FGFR3 | 1.00109165 |
| 72 | PIM1 | 0.97750255 |
| 73 | RIPK1 | 0.93928932 |
| 74 | WNK1 | 0.92903244 |
| 75 | PIK3CA | 0.92742077 |
| 76 | FGR | 0.90426946 |
| 77 | MAPK15 | 0.90385333 |
| 78 | NLK | 0.89810075 |
| 79 | DYRK1A | 0.89532270 |
| 80 | NTRK3 | 0.88209811 |
| 81 | LRRK2 | 0.88208967 |
| 82 | ITK | 0.87104983 |
| 83 | BMX | 0.86761712 |
| 84 | MARK2 | 0.85142155 |
| 85 | LYN | 0.84925585 |
| 86 | SGK494 | 0.83660772 |
| 87 | SGK223 | 0.83660772 |
| 88 | DYRK1B | 0.80789240 |
| 89 | MAP2K4 | 0.79229375 |
| 90 | PBK | 0.78855266 |
| 91 | FRK | 0.77271687 |
| 92 | MATK | 0.76656919 |
| 93 | GRK7 | 0.75665480 |
| 94 | EGFR | 0.75276585 |
| 95 | TRPM7 | 0.71766473 |
| 96 | NEK2 | 0.70735830 |
| 97 | RPS6KA4 | 0.70010004 |
| 98 | ADRBK1 | 0.68698582 |
| 99 | MAPK13 | 0.68637567 |
| 100 | ABL1 | 0.68135482 |
| 101 | ADRBK2 | 0.67233349 |
| 102 | TGFBR1 | 0.66124723 |
| 103 | PDGFRB | 0.64246524 |
| 104 | CLK1 | 0.64050542 |
| 105 | TESK2 | 0.63894537 |
| 106 | INSRR | 0.61682371 |
| 107 | CAMKK2 | 0.60936624 |
| 108 | MAP4K2 | 0.60390018 |
| 109 | ZAK | 0.59509334 |
| 110 | NTRK2 | 0.59372548 |
| 111 | TEC | 0.58676517 |
| 112 | YES1 | 0.57168421 |
| 113 | TYRO3 | 0.56605700 |
| 114 | MAPK7 | 0.55923210 |
| 115 | MAP2K2 | 0.54592045 |
| 116 | SGK1 | 0.54506750 |
| 117 | MAP3K3 | 0.52884701 |
| 118 | PTK2B | 0.52877663 |
| 119 | MAP3K8 | 0.51964268 |
| 120 | PRKCQ | 0.51179205 |
| 121 | RET | 0.51144615 |
| 122 | DYRK3 | 0.50019296 |
| 123 | MTOR | 0.49470405 |
| 124 | ALK | 0.49001981 |
| 125 | TAF1 | 0.48292441 |
| 126 | CDK3 | 0.47977656 |
| 127 | RPS6KA2 | 0.46925348 |
| 128 | CAMK4 | 0.46831902 |
| 129 | HIPK2 | 0.45236028 |
| 130 | STK38L | 0.45205445 |
| 131 | GSK3A | 0.45140378 |
| 132 | PDK1 | 0.44617902 |
| 133 | SGK3 | 0.43105247 |
| 134 | GRK6 | 0.40217113 |
| 135 | SIK3 | 0.39128848 |
| 136 | PKN1 | 0.38585553 |
| 137 | FYN | 0.37282649 |
| 138 | PIM2 | 0.36307087 |
| 139 | EPHA3 | 0.36028634 |
| 140 | PDPK1 | 0.35814511 |
| 141 | ERBB2 | 0.35620667 |
| 142 | EIF2AK2 | 0.34160782 |
| 143 | NTRK1 | 0.28705753 |
| 144 | PAK2 | 0.28657423 |
| 145 | IGF1R | 0.28529349 |
| 146 | RPS6KA6 | 0.28496073 |
| 147 | ABL2 | 0.28020564 |
| 148 | SRC | 0.27115951 |
| 149 | MAP3K5 | 0.26995088 |
| 150 | PRKCD | 0.26972415 |
| 151 | MELK | 0.25574741 |
| 152 | INSR | 0.25122370 |
| 153 | PRKD1 | 0.24835352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.10553095 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.83343565 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.44428747 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.43326899 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.29422893 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.25824995 |
| 7 | Lysosome_Homo sapiens_hsa04142 | 2.25557831 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.14675231 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 1.96115506 |
| 10 | Malaria_Homo sapiens_hsa05144 | 1.92799535 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 1.83281812 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 1.83142574 |
| 13 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.77851073 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.75039259 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.74826196 |
| 16 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.73280473 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.68633446 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.68548683 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.68416631 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.58294848 |
| 21 | Phototransduction_Homo sapiens_hsa04744 | 1.53514642 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.52686444 |
| 23 | Phagosome_Homo sapiens_hsa04145 | 1.51378748 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.51143743 |
| 25 | Apoptosis_Homo sapiens_hsa04210 | 1.49643964 |
| 26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.45103110 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.43623552 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42479819 |
| 29 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.42345505 |
| 30 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.41953430 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.40562619 |
| 32 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.38731779 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.34014394 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.32162804 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.29333178 |
| 36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.27834084 |
| 37 | Taste transduction_Homo sapiens_hsa04742 | 1.27472918 |
| 38 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.26366174 |
| 39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.25951505 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.25606299 |
| 41 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.23848926 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.23716593 |
| 43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.19870887 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.18868009 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.18570662 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16435731 |
| 47 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.14842992 |
| 48 | Long-term depression_Homo sapiens_hsa04730 | 1.11927743 |
| 49 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.10465928 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 1.10152716 |
| 51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09155768 |
| 52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.08721395 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 1.08656320 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08001538 |
| 55 | Amoebiasis_Homo sapiens_hsa05146 | 1.07810334 |
| 56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.06527085 |
| 57 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.03464420 |
| 58 | Salmonella infection_Homo sapiens_hsa05132 | 1.02495456 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00770640 |
| 60 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.00532154 |
| 61 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.98744443 |
| 62 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.98153064 |
| 63 | Allograft rejection_Homo sapiens_hsa05330 | 0.95651654 |
| 64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.94486749 |
| 65 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.94471687 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93821993 |
| 67 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.92363160 |
| 68 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.91846261 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 0.90353678 |
| 70 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.89359835 |
| 71 | Renin secretion_Homo sapiens_hsa04924 | 0.88315353 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87338117 |
| 73 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.87125896 |
| 74 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.86817303 |
| 75 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.86608708 |
| 76 | ABC transporters_Homo sapiens_hsa02010 | 0.85922454 |
| 77 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.85797950 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.85492661 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.84575909 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83029606 |
| 81 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83009891 |
| 82 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.83000037 |
| 83 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.82488073 |
| 84 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.79151283 |
| 85 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.78188930 |
| 86 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.77873892 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75933652 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75927226 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75709250 |
| 90 | Morphine addiction_Homo sapiens_hsa05032 | 0.74857343 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74598599 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74560856 |
| 93 | Platelet activation_Homo sapiens_hsa04611 | 0.73729466 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72037057 |
| 95 | Lysine degradation_Homo sapiens_hsa00310 | 0.71871580 |
| 96 | Homologous recombination_Homo sapiens_hsa03440 | 0.71003593 |
| 97 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70598036 |
| 98 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.70534046 |
| 99 | Asthma_Homo sapiens_hsa05310 | 0.69527796 |
| 100 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.68919372 |
| 101 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68256494 |
| 102 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67829961 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.66289677 |
| 104 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65652235 |
| 105 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.65513229 |
| 106 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65382565 |
| 107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65281365 |
| 108 | Olfactory transduction_Homo sapiens_hsa04740 | 0.65004212 |
| 109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64754306 |
| 110 | Salivary secretion_Homo sapiens_hsa04970 | 0.63960277 |
| 111 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.63694565 |
| 112 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.63211700 |
| 113 | Circadian entrainment_Homo sapiens_hsa04713 | 0.62983000 |
| 114 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.62202140 |
| 115 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.62200933 |
| 116 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.61794805 |
| 117 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60743304 |
| 118 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.57559784 |
| 119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57526033 |
| 120 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57223743 |
| 121 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57156951 |
| 122 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.56167650 |
| 123 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55235007 |
| 124 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55001760 |
| 125 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.54985572 |
| 126 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.54711416 |
| 127 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.54673740 |
| 128 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53929166 |
| 129 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53781398 |
| 130 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50786948 |
| 131 | Focal adhesion_Homo sapiens_hsa04510 | 0.50636661 |
| 132 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50524841 |
| 133 | Prostate cancer_Homo sapiens_hsa05215 | 0.50198507 |
| 134 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.50072770 |
| 135 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49199034 |
| 136 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48634107 |
| 137 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.48514835 |
| 138 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48463532 |
| 139 | Endocytosis_Homo sapiens_hsa04144 | 0.48160361 |
| 140 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47861953 |
| 141 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.47461711 |
| 142 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46551117 |
| 143 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46504046 |
| 144 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46303206 |
| 145 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.46207224 |
| 146 | Colorectal cancer_Homo sapiens_hsa05210 | 0.46166254 |
| 147 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46062471 |
| 148 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45998013 |
| 149 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.45195997 |
| 150 | Prion diseases_Homo sapiens_hsa05020 | 0.44403475 |
| 151 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42527255 |
| 152 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41746644 |

